As part of the partnership, Boehringer Ingelheim will provide access to its opnMe® platform, enabling broader scientific exchange and driving innovation-led research.
The summit brought together over 150 doctors, researchers, and practitioners worldwide
The acquisition brings three established small-molecule drug substance facilities into Siegfried’s global network
The capacity addition to be implemented in a phased manner amid evolving business and market dynamics
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Move to accelerate cancer care expansion across India
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
